Please select the outcome measures that correspond to the clinical trial below.
Title: Stories for Change: Digital Storytelling for Diabetes Self-Management Among Hispanic Adults
Brief Summary: Hispanic adults are twice as likely to have type 2 diabetes mellitus (T2D) and 1.5 times more likely to die from the disease than non-Hispanic whites. These disparities are mediated, in part, by less healthful levels of physical activity, dietary quality, medication adherence, and self-monitoring of blood glucose than non-Hispanic whites. Innovative approaches that arise from affected communities are needed to address these health disparities.

Community-based participatory research (CBPR) has been successful in targeting health issues among Hispanic and immigrant populations; CBPR is an effective approach for addressing health behaviors in a sociocultural context. In 2004, the research team developed a CBPR partnership between immigrant communities and academic institutions called Rochester Healthy Community Partnership (RHCP)

Storytelling or narrative-based interventions are designed to incorporate culture-centric health messaging to promote behavior change among vulnerable populations. Digital storytelling interventions are narrative-based videos elicited through a CBPR approach to surface the authentic voices of individuals overcoming obstacles toward engaging in health promoting behaviors to shape positive health behaviors of viewers through influences on attitudes and beliefs.

RHCP partners from Hispanic communities identified T2D as a priority area for intervention, and have co-created each of the formative phases leading up to this proposal. Narrative theory and social cognitive theory formed the conceptual basis for intervention development. The study team conducted surveys and focus groups to derive the approach and personnel for building an authentic intervention that was created in a digital storytelling workshop where stories about diabetes self-management were captured, recorded, and edited to derive the final intervention products in video forma. The respective digital storytelling videos were pilot tested with 25 patients across healthcare institutions in Minnesota and Arizona. The intervention was rated as highly acceptable, culturally relevant, and perceived as efficacious for motivating behavioral change.

The overall objective of this project is therefore to assess the efficacy of a digital storytelling intervention derived through a CBPR approach on self-management of T2D among Hispanic adults.


Options:
A: Score of Seattle Angina Questionnaire（SAQ ） (at the 0-week); Score of Seattle Angina Questionnaire（SAQ ） (at the 4-week); Score of Seattle Angina Questionnaire（SAQ ） (at the 8-week); Score of Seattle Angina Questionnaire（SAQ ） (at the 12-week); Frequency of angina pectoris related symptoms every week (at the 0-week); Frequency of angina pectoris related symptoms every week (at the 1-week); Frequency of angina pectoris related symptoms every week (at the 2-week); Frequency of angina pectoris related symptoms every week (at the 3-week); Frequency of angina pectoris related symptoms every week (at the 4-week); Frequency of angina pectoris related symptoms every week (at the 5-week); Frequency of angina pectoris related symptoms every week (at the 6-week); Frequency of angina pectoris related symptoms every week (at the 7-week); Frequency of angina pectoris related symptoms every week (at the 8-week); Frequency of angina pectoris related symptoms every week (at the 9-week); Frequency of angina pectoris related symptoms every week (at the 10-week); Frequency of angina pectoris related symptoms every week (at the 11-week); Frequency of angina pectoris related symptoms every week (at the 12-week)
B: Glycemic Control as Measured by Hemoglobin A1c at Baseline and 3 Months (Baseline and 3 months.)
C: Diet. Starting the Conversation is a 9 items measure of eating patterns (including 2 items from the NCI Fruit and Vegetable Screener). NCI Percent Energy from Fat Screen (PFAT) contains 17 items concerning frequency of intake for 15 food groups. (Baseline, 16 weeks, and 12 months); Physical Activity. The CHAMPS (28 items) will be used to measure physical activity. (Baseline, 16 weeks, and 12 months); Medication Adherence. Medication taking will be assessed by the Hill-Bone Medication Adherence scale. Questions will also cover smoking and alcohol use. (Baseline, 16 weeks, and 12 months); Distress. Patient distress will be assessed across several measures including: the 20-item CES-D, the 17-item DDS, the PHQ8, and screening items from the SCID to rule out psychosis. (Baseline, 16 weeks, and 12 months)
D: Weight loss (6-12 months)

Answer: B